Opinion statement
In 2001, the incidence of primary and secondary syphilis increased in the United States for the first time in a decade. Increasing rates of early syphilis among men who have sex with men have been reported in many American cities, with similar outbreaks noted in Canada and Europe. In San Francisco, the increase has been particularly sharp and accompanied by an increase in the incidence of neurosyphilis. Early neurosyphilis develops within weeks to years of primary infection and primarily involves the meninges. Syndromes include syphilitic meningitis (often accompanied by cranial neuropathies), meningovascular syphilis (with associated ischemic stroke), or asymptomatic neurosyphilis. Late neurosyphilis occurs years to decades after exposure as cerebral or spinal gummatous disease or the classic parenchymal forms affecting the brain (general paresis or syphilitic encephalitis) or spinal cord and nerve roots (tabes dorsalis). Treponema pallidum, the causative agent, cannot be cultured in vitro, and microscopic techniques are laborious. Thus, diagnosis depends on serologic tests and cerebrospinal fluid (CSF) examination. The suboptimal sensitivity and specificity of these tests complicate diagnosis, particularly among patients coinfected with HIV. CSF examination should be performed to evaluate for neurosyphilis in all patients with positive serum syphilis serology and neurologic, ophthalmic, or tertiary disease, or in those who have failed therapy, and in HIVinfected patients with late latent syphilis or syphilis of unknown duration. Intravenous penicillin G is the recommended treatment for all forms of neurosyphilis and for syphilitic eye disease. An outpatient alternative, if adherence can be assured, is intramuscular benzathine penicillin with oral probenecid. Newer drugs that penetrate CSF, such as ceftriaxone or azithromycin, have not yet been adequately tested for neurosyphilis. Syphilis facilitates transmission of HIV (and vice versa), and thus all patients diagnosed with syphilis should be offered HIV testing.
Similar content being viewed by others
References and Recommended Reading
Peterman TA, Heffelfinger JD, Swint EB, Groseclose SL: The changing epidemiology of syphilis. Sex Transm Dis 2005, 32(Suppl 10):S4-S10. This up-to-date review of syphilis epidemiology discusses the evolving epidemic, with an emphasis on the United States.
Marra CM: Syphilis and human immunodeficiency virus--prevention and politics. Arch Neurol 2004, 61:1505–1508.
Centers for Disease Control and Prevention: Primary and secondary syphilis--United States, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:1117–1120.
Hook EW, Peeling RW: Syphilis control--a continuing challenge. N Engl J Med 2004, 351:122–124. This succinct discussion of the global impact of syphilis emphasizes the need for simple, inexpensive, and effective testing and treatment.
San Francisco Department of Public Health: San Francisco sexually transmitted disease annual report, 2004. http://www.dph.sf.ca.us/reports/std/ sfstdannlsum2004.pdf. Accessed December 11, 2005.
Zellan J, Augenbraun M: Syphilis in the HIV-infected patient: an update on epidemiology, diagnosis, and management. Curr HIV/AIDS Rep 2004, 1:142–147.
Buchacz K, Patel P, Taylor M, et al.: Syphilis increases HIV viral load and decreases CD4 cell counts in HIVinfected patients with new syphilis infections. AIDS 2004, 18:2075–2079.
Lynn WA, Lightman S: Syphilis and HIV: a dangerous combination. Lancet Infect Dis 2004, 4:456–466.
Golden MR, Marra CM, Holmes KK: Update on syphilis: resurgence of an old problem. JAMA 2003, 290:1510–1514. This concise review emphasizes the natural history, clinical features, and management of syphilis.
Zeltzer R, Kurban AK: Syphilis. Clin Dermatol 2004, 22:461–468.
MarraCM: Neurosyphilis. Curr Neurol Neurosci Rep 2004, 4:435–440. This highly readable review interprets recent clinical research in the context of common clinical dilemmas.
Lukeheart SA, Hook EW, Baker-Zander SA, et al.: Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 1988, 109:855–862.
Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337:307–314.
O’Donnell JA, Emery CL: Neurosyphilis: a current review. Curr Infect Dis Rep 2005, 7:277–284.
Timmermans M, Carr J: Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatr 2004, 75:1727–1730.
Kiss S, Damico FM, Young LH: Ocular manifestations and treatment of syphilis. Semin Ophthalmol 2005, 20:161–167.
Pletcher SD, Cheung SW: Syphilis and otolaryngology. Otolaryngol Clin N Am 2003, 36:595–605.
Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002, 51:18–30. These guidelines, published every several years, include CDC recommendations for treatment of all forms of syphilis, including neurosyphilis, and indications for examination. New guidelines are due in the first quarter of 2006 and will be available at the CDC website, http://www.cdc.gov/std/treatment/, or at the Morbidity and Mortality Weekly Report website, http://www.cdc.gov/mmwr/.
Chan DJ: Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 2005, 3:95–98.
MarraCM, Maxwell CL, Smith SL, et al.: Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004, 189:369–376. This large study identified high serum VDRL titers and low CD4 count as risk factors for neurosyphilis.
Marra CM, Maxwell CL, Tantalo L, et al.: Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin Infect Dis 2004, 38:1001–1006.
Marra CM, Boutin P, McArthur JC, et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis 2000, 30:540–544.
Marra CM, Tantalo LC, Maxwell CL, et al.: Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology 2004, 63:85–88.
Parkes R, Renton A, Meheus A, Laukamm-Josten U: Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004, 15:73–88.
Centers for Disease Control and Prevention: Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medical Association/Infectious Diseases Society of North America. MMWR Morb Mortal Wkly Rep 2004, 53:27–30.
Ali L, Roos KL: Antibacterial therapy of neurosyphilis: lack of impact of new therapies. CNS Drugs 2002, 16:799–802.
Klasco RK: DRUGDEX® System. Greenwood Village, CO: Thomsom Micromedex; 2005.
Silberstein P, Lawrence R, Pryor D, Shnier R: A case of neurosyphilis with a florid Jarisch-Herxheimer reaction. J Clin Neurosci 2002, 9:689–690.
Pao D, Goh BT, Bingham JS: Management issues in syphilis. Drugs 2002, 62:1447–1461.
Centers for Disease Control and Prevention: Inadvertent use of Bicillin-CR to treat syphilis infection--Los Angeles, California, 1999–2004. MMWR Morb Mortal Wkly Rep 2005, 54:217–219.
Mullin P, Green G, Bakshi R: Special populations: the management of seizures in HIV-positive patients. Curr Neurol Neurosci Rep 2004, 4:308–314.
Lim ML, Min SS, Eron JJ, et al.: Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P450 induction. J Acquir Immune Defic Syndr 2004, 36:1034–1040.
Hugen PWH, Burger DM, Brinkman K, et al.: Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother 2000, 34:465–470.
Smith NH, Musher DM, Huang DB, et al.: Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular ceftriaxone or procaine penicillin. Int J STD AIDS 2004, 15:328–332.
Centers for Disease Control and Prevention: Brief report: azithromycin treatment failures in syphilis infections--San Francisco, California, 2002–2003. MMWR Morb Mortal Wkly Rep 2004, 53:197–198.
Lukehart SA, Godornes C, Molini BJ, et al.: Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004, 251:154–158.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jay, C.A. Treatment of neurosyphilis. Curr Treat Options Neurol 8, 185–192 (2006). https://doi.org/10.1007/s11940-006-0009-7
Issue Date:
DOI: https://doi.org/10.1007/s11940-006-0009-7